bupropion hydrochloride (xl)

Generic: bupropion hydrochloride

Labeler: golden state medical supply, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name bupropion hydrochloride (xl)
Generic Name bupropion hydrochloride
Labeler golden state medical supply, inc.
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

bupropion hydrochloride 150 mg/1

Manufacturer
Golden State Medical Supply, Inc.

Identifiers & Regulatory

Product NDC 51407-206
Product ID 51407-206_447188f5-1076-885a-e063-6294a90ae7c5
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA210081
Listing Expiration 2026-12-31
Marketing Start 2017-11-03

Pharmacologic Class

Classes
aminoketone [epc] dopamine uptake inhibitors [moa] increased dopamine activity [pe] increased norepinephrine activity [pe] norepinephrine uptake inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 51407206
Hyphenated Format 51407-206

Supplemental Identifiers

RxCUI
993541 993557
UNII
ZG7E5POY8O

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bupropion hydrochloride (xl) (source: ndc)
Generic Name bupropion hydrochloride (source: ndc)
Application Number ANDA210081 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51407-206-05)
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51407-206-30)
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51407-206-90)
source: ndc

Packages (3)

51407-206-05 500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51407-206-05) 51407-206-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51407-206-30) 51407-206-90 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51407-206-90)

Ingredients (1)

bupropion hydrochloride (150 mg/1)

Linked Drug Pages (1)

Bupropion Hydrochloride (XL) ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "447188f5-1076-885a-e063-6294a90ae7c5", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["8722a60e-7635-7455-e053-2991aa0abaf7"], "manufacturer_name": ["Golden State Medical Supply, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51407-206-05)", "package_ndc": "51407-206-05", "marketing_start_date": "20190225"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51407-206-30)", "package_ndc": "51407-206-30", "marketing_start_date": "20190225"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51407-206-90)", "package_ndc": "51407-206-90", "marketing_start_date": "20190225"}], "brand_name": "Bupropion Hydrochloride (XL)", "product_id": "51407-206_447188f5-1076-885a-e063-6294a90ae7c5", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "51407-206", "generic_name": "bupropion hydrochloride", "labeler_name": "Golden State Medical Supply, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "(XL)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA210081", "marketing_category": "ANDA", "marketing_start_date": "20171103", "listing_expiration_date": "20261231"}